产品
编 号：F186614
分子式：C10H24Cl2N3O2P
分子量：320.2
分子式：C10H24Cl2N3O2P
分子量：320.2
产品类型
规格
价格
是否有货
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
结构图
CAS No: 1566-15-0
产品详情
生物活性：
Phosphoramide mustard cyclohexanamine is a biologically active metabolite of Cyclophosphamide (HY-17420), with anticancer activitiy. Phosphoramide mustard cyclohexanamine induces DNA damage.
体内研究：
Phosphoramide mustard cyclohexanamine (2.1-20.7 mg/kg; i.p.; daily; for 5 days) inhibits subcutaneous tumor growth in rats.?Phosphoramide mustard cyclohexanamine exhibits terminal elimination half-lives (rat 15.1 min) following intravenous administration (rat 59.4 mg/kg).Animal Model:Rat, subcutaneously implanted Walker 256 carcinosarcoma tumor
Dosage:2.1 mg/kg, 4.8 mg/kg, 10.4 mg/kg, 20.7 mg/kg
Administration:Intraperitoneal injection, once daily, for 5 consecutive days
Result:Required to produce 50% inhibition of subcutaneous tumor growth with dose of 12 mg/kg.
Animal Model:Rats
Dosage:86.0 mg/kg (Pharmacokinetic Analysis)
Administration:Intravenous injection
Result:T1/2 (15.1 min).
体外研究：
Phosphoramide mustard cyclohexanamine causes cytotoxicity through forming cross-linked DNA adducts which inhibit DNA strand separation during replication.Phosphoramide mustard cyclohexanamine (3-6 μM; 48 hours) reduces cell viability in rat spontaneously immortalized granulosa cells (SIGCs).Phosphoramide mustard cyclohexanamine (3-6 μM; 24-48 hours) induces DNA adduct formation and ovarian DNA damage.Phosphoramide mustard cyclohexanamine (3-6 μM; 24-48 hours) increases DNA damage responses (DDR) gene mRNA expression levels and DDR proteins.
Phosphoramide mustard cyclohexanamine is a biologically active metabolite of Cyclophosphamide (HY-17420), with anticancer activitiy. Phosphoramide mustard cyclohexanamine induces DNA damage.
体内研究：
Phosphoramide mustard cyclohexanamine (2.1-20.7 mg/kg; i.p.; daily; for 5 days) inhibits subcutaneous tumor growth in rats.?Phosphoramide mustard cyclohexanamine exhibits terminal elimination half-lives (rat 15.1 min) following intravenous administration (rat 59.4 mg/kg).Animal Model:Rat, subcutaneously implanted Walker 256 carcinosarcoma tumor
Dosage:2.1 mg/kg, 4.8 mg/kg, 10.4 mg/kg, 20.7 mg/kg
Administration:Intraperitoneal injection, once daily, for 5 consecutive days
Result:Required to produce 50% inhibition of subcutaneous tumor growth with dose of 12 mg/kg.
Animal Model:Rats
Dosage:86.0 mg/kg (Pharmacokinetic Analysis)
Administration:Intravenous injection
Result:T1/2 (15.1 min).
体外研究：
Phosphoramide mustard cyclohexanamine causes cytotoxicity through forming cross-linked DNA adducts which inhibit DNA strand separation during replication.Phosphoramide mustard cyclohexanamine (3-6 μM; 48 hours) reduces cell viability in rat spontaneously immortalized granulosa cells (SIGCs).Phosphoramide mustard cyclohexanamine (3-6 μM; 24-48 hours) induces DNA adduct formation and ovarian DNA damage.Phosphoramide mustard cyclohexanamine (3-6 μM; 24-48 hours) increases DNA damage responses (DDR) gene mRNA expression levels and DDR proteins.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备